NCT00595465已完成3 期
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Controlled Phase 3 Study.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 389
- 试验地点
- 8
- 主要终点
- Geometric Mean Titer (GMT) for Anti-JEV Neutralizing Antibody
研究概览
简要总结
The objective is to demonstrate equivalence of three commercial IC51 batches in terms of geometric mean titers for anti-JEV neutralizing antibody
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male and female healthy adults aged at least 18 years, with written informed consent and either no childbearing potential or negative pregnancy test
排除标准
- •History of immunodeficiency or immunosuppressive therapy,
- •Known Human Immunodeficiency Virus (HIV); OR
- •Drug addiction including alcohol dependence
结局指标
主要结局
Geometric Mean Titer (GMT) for Anti-JEV Neutralizing Antibody
时间窗: Day 56
次要结局
- Seroconversion Rate(Day 56)
- Safety and Adverse Events(Day 56)
研究者
研究点 (8)
Loading locations...
相似试验
已完成
3 期
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51Japanese EncephalitisNCT00594958Valneva Austria GmbH639
已完成
3 期
Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post FillingJapanese EncephalitisNCT00776230Valneva Austria GmbH304
进行中（未招募）
不适用
COMPARISON OF THREE COMMERCIAL BATCHES OF THE JAPANESE ENCEPHALITIS VACCINE IC51. DOUBLE BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDYEUCTR2007-002771-14-DEIntercell AG384
进行中（未招募）
不适用
COMPARISON OF THREE COMMERCIAL BATCHES OF THE JAPANESE ENCEPHALITIS VACCINE IC51. DOUBLE BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDYEUCTR2007-002771-14-ATIntercell AG384
进行中（未招募）
不适用
COMPARISON OF THREE BATCHES OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (JE-PIV). DOUBLE BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDY.Japanese encephalitisEUCTR2006-002076-18-DEIntercell AG624